Elevated levels of HOXA10 can potentially serve as a prognostic biomarker for GC (Han et al. 2015), and overexpression of HOXC10 can enhance both the proliferation and migration of GC cells through the activation of MAPK and NF-κB pathways (Kim et al. 2019). The gene discussed is HOXC10; the disease is gastric cancer.